A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
Clinical trial NCT05769660 · RECRUITING
Trial details
- NCT number
- NCT05769660
- Sponsor
- BeyondBio Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-29
- Primary completion
- 2026-11-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.